Search bioRxiv⌕ Search

Biology subjects

Simeonova, I.

Publications and source records attributed to Simeonova, I..

4 recordsLinked to original sources

Whole-Embryo 3D Quantification Reveals Conserved Topological Design and Scaling of Germ Layers in Xenopus

How embryos with markedly different absolute sizes and cell numbers establish comparable tissue organization during development remains a fundamental question in developmental biology. To address this question, we compared two closely related Xenopus species that differ substantially in embryonic size, Xenopus laevis and Xenopus tropicalis. We generated a whole-embryo quantitative 3D atlas of cell allocation, spatial organization, and mitotic dynamics at key time points between gastrulation to tailbud stages. Using tissue clearing, and 3D imaging we tracked single-nucleus coordinates across developmental milestones to resolve how body plans adapt to organismal scale. We show that embryonic scaling is not achieved through simple proportional changes in cell number. Instead, the smaller X. tropicalis embryo is characterized by a distinct high-density tissue organization associated with a persistently higher mitotic index (~1.4-fold higher than in X. laevis at both gastrula and tailbud stages). Across development, this is accompanied by a near-doubling of cell number in X. tropicalis without a proportional increase in embryo volume. We quantify tissue organization and find species-specific cellular architectures during gastrulation that largely converge by the tailbud stage. At this stage, homologous tissues display broadly similar structural profiles despite persistent differences in embryo size, cell number, and density. Together, our findings reveal that closely related vertebrate embryos can follow distinct cellular organization trajectories while converging toward comparable tissue architecture, providing a quantitative framework for understanding robust body plan formation across divergent physical scales.

Developmental Biology↗

An optimized workflow for spatial transcriptomics across early development in Xenopus

How gene expression patterns change spatially as the embryo transitions from simple to complex structures remains a major developmental biology question. Recently developed imaging-based spatial transcriptomics (ST) enable mapping expression of multiple gene at a single-cell resolution. Although Xenopus is a key model in embryology there is no established ST pipeline, and commercially available techniques face many challenges (sample preparation, probe design, cell segmentation). Furthermore, the highly diverse cell shapes and sizes across developmental stages and between different tissues represent major hurdles to accurately defining cells. Here, we describe an optimized workflow for ST in blastula-to-tailbud-stage frog embryos using Merscope, commercial MERFISH (Multiplexed Error-Robust Fluorescence In Situ Hybridization) originally designed for standard mammalian tissues. With stringent quality control and tailored computational pipelines, we optimize this technology for robust, semi-quantitative profiling of spatial transcriptomic landscapes in non-mammalian embryos. Reliable tissue preservation and cell-segmentation enable high-resolution mapping of gene expression during the development of a complex multi-tissue organization. This versatile strategy applies broadly to various dynamic systems, from embryos of various model organisms to complex and heterogeneous organs in mammals. Summary statementThis Single-cell Spatial Transcriptomics pipeline and reference atlas in Xenopus - a model organism in embryology - overcome technical challenges and resolve dynamic changes in patterning during development.

developmental biology↗

Oncogenic and teratogenic effects of p53Y217C, a mouse model of the human hotspot mutant p53Y220C

Missense "hotspot" mutations localized in six p53 codons account for 20% of TP53 mutations in human cancers. Hotspot p53 mutants have lost the tumor suppressive functions of the wildtype protein, but whether and how they may gain additional functions promoting tumorigenesis remain controversial. Here we generated Trp53Y217C, a mouse model of the human hotspot mutant TP53Y220C. DNA damage responses were lost in Trp53Y217C/Y217C cells, and Trp53Y217C/Y217C fibroblasts exhibited increased chromosome instability compared to Trp53-/- cells. Furthermore, Trp53Y217C/Y217C male mice died earlier than Trp53-/- males, with more aggressive thymic lymphomas. This correlated with an increased expression of inflammation-related genes in Trp53Y217C/Y217C thymic cells compared to Trp53-/- cells. Surprisingly, we recovered only one Trp53Y217C/Y217C female for 22 Trp53Y217C/Y217C males at weaning, a skewed distribution explained by a high frequency of Trp53Y217C/Y217C female embryos with exencephaly and the death of most Trp53Y217C/Y217C female neonates. Strikingly however, when we treated pregnant females with the anti-inflammatory drug supformin (LCC-12) we observed a five-fold increase in the proportion of viable Trp53Y217C/Y217C weaned females in their progeny. Together, these data suggest that the p53Y217C mutation not only abrogates wildtype p53 functions but also promotes inflammation, with oncogenic effects in males and teratogenic effects in females.

cancer biology↗

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas

The Trp53 gene encodes several isoforms of elusive biological significance. Here we show that mice lacking the Trp53 Alternatively Spliced (AS) exon, thereby expressing the canonical p53 protein but not isoforms with the AS C-terminus, have unexpectedly lost a male-specific protection against Myc-induced B-cell lymphomas. Lymphomagenesis was delayed in p53+/+ E-Myc males compared to p53{Delta}AS/{Delta}AS E-Myc males, but also compared to p53+/+ E-Myc and p53{Delta}AS/{Delta}AS E-Myc females. Pre-tumoral splenic cells from p53+/+ E-Myc males exhibited a higher expression of Ackr4, encoding an atypical chemokine receptor with tumor suppressive effects. We identified Ackr4 as a p53 target gene whose p53-mediated transactivation is inhibited by estrogens, and as a male-specific factor of good prognosis relevant for murine E-Myc-induced and human Burkitt lymphomas. Furthermore, the knockout of ACKR4 increased the chemokine-guided migration of Burkitt lymphoma cells. These data demonstrate the functional relevance of alternatively spliced p53 isoforms and reveal sex disparities in Myc-driven lymphomagenesis.

cancer biology↗